BioNTech and OncoC4 Report Longer Survival With Gotistobart Updated stage-one data favored gotistobart over chemotherapy in previously treated squamous lung cancer, while the...

https://www.narrowit.com/news/biontech-oncoc4-gotistobart-survival-data-2026-09-14
#Biontech #BNTX #Oncoc4 #Gotistobart